Skip to main content
main-content

01.08.2011 | Research article | Ausgabe 4/2011 Open Access

Arthritis Research & Therapy 4/2011

A targeted lipidomics approach to the study of eicosanoid release in synovial joints

Zeitschrift:
Arthritis Research & Therapy > Ausgabe 4/2011
Autoren:
Janny C de Grauw, Chris HA van de Lest, Paul René van Weeren
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​ar3427) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JCdG carried out the sample collection and extractions, participated in method optimization, and drafted the manuscript. CHAvdL carried out the HPLC-MS/MS optimization and data analysis and performed the statistical analysis. PRvW participated in the design and coordination of the study and helped to draft the manuscript. All authors read and approved the final manuscript.

Abstract

Introduction

Articular tissues are capable of producing a range of eicosanoid mediators, each of which has individual biological effects and may be affected by anti-inflammatory treatment. We set out to develop and evaluate a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) approach for the simultaneous analysis of multiple eicosanoid lipid mediators in equine synovial fluid (SF), and to illustrate its use for investigation of the in vivo effects of non-steroidal anti-inflammatory drug (NSAID) treatment.

Methods

Synovial fluid samples were obtained from normal joints of 6 adult horses at baseline (0 hr) and at 8, 24 and 168 hours after experimental induction of transient acute synovitis, with horses treated once daily with oral NSAID (meloxicam, 0.6 mg/kg) or placebo. Following solid-phase extraction, SF lipid mediator quantitation was based on liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) analysis, and results were compared between disease states using linear discriminant analysis (LDA) and analysis of variance (ANOVA) with multiple comparisons corrections.

Results

Of a total of 23 mediators targeted, 14 could be reliably identified and quantified in SF samples based on detection of characteristic fragment ions at retention times similar to those of commercial standards. LDA analysis of baseline, 8, 24 and 168 hour synovial fluid samples revealed a separation of these groups into discrete clusters, reflecting dynamic changes in eicosanoid release over the course of synovitis. Prostaglandin (PG) E2 was significantly lower in NSAID vs. placebo treated samples at all time points; PGE1, 11-hydroxyeicosatetraenoic acid (11-HETE) and 13,14-dihydro-15keto PGF2α were reduced at 8 and 24 hours by NSAID treatment; while 15-HETE, 6-keto PGF1α, PGF2α, 13,14-dihydro-15keto PGE2 and thromboxane B2 (TXB2) were reduced at the 8 hour time point only. An interesting pattern was seen for Leukotriene B4 (LTB4), NSAID treatment causing an initial increase at 8 hours, but a significant reduction by 168 hours.

Conclusions

The described method allows a comprehensive analysis of synovial fluid eicosanoid profiles. Eicosanoid release in inflamed joints as well as differences between NSAID treated and placebo treated individuals are not limited to PGE2 or to the early inflammatory phase.
Zusatzmaterial
Additional file 1: Calibration lines - Standard curve equations and correlation coefficients for LC-ESI-MS/MS analysis of eicosanoid standards. Calibration lines for liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) analysis were prepared by diluting stock solutions to final concentrations of 100 pg/μL, 50 pg/μL, 25 pg/μL, 10 pg/μL, 5 pg/μL, 2 pg/μL and 1 pg/μL. The internal standard (IS; 16,16-dimethyl prostaglandin F2α) was prepared in ethanol (2 ng/μL) and added to all composite standards at a final concentration of 100 pg/μL. (PDF 49 KB)
13075_2011_3185_MOESM1_ESM.PDF
Authors’ original file for figure 1
13075_2011_3185_MOESM2_ESM.pdf
Authors’ original file for figure 2
13075_2011_3185_MOESM3_ESM.pdf
Authors’ original file for figure 3
13075_2011_3185_MOESM4_ESM.pdf
Authors’ original file for figure 4
13075_2011_3185_MOESM5_ESM.pdf
Authors’ original file for figure 5
13075_2011_3185_MOESM6_ESM.jpeg
Authors’ original file for figure 6
13075_2011_3185_MOESM7_ESM.jpeg
Authors’ original file for figure 7
13075_2011_3185_MOESM8_ESM.jpeg
Authors’ original file for figure 8
13075_2011_3185_MOESM9_ESM.jpeg
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2011

Arthritis Research & Therapy 4/2011 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise